Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Amgen Tops Wall Street Fourth Quarter Forecasts

January 28, 2015 8:12 am | by LINDA A. JOHNSON, AP Business Writer | News | Comments

The world's biggest biotech drugmaker by revenue said it's starting a cycle of several important new product launches — big enough that last year it announced major job reductions and other cost cuts to free up money for the launches.   

TOPICS:

PPD Expands Clinical Supplies Facility in Athlone, Ireland

January 28, 2015 8:07 am | News | Comments

Pharmaceutical Product Development, (PPD) has completed an expansion of its clinical supplies facility in Athlone, Ireland, that will enable the company to double its packaging warehousing capabilities and quadruple its distribution services. Those increases are the result of PPD more than tripling the size of the facility as part of its long-term strategy to expand its global depot network.

TOPICS:

Report: Single-Use Bioreactors Market to Grow to $471M by 2019

January 28, 2015 8:02 am | News | Comments

The single use bioreactors (SUBs) market is expected to grow at a double digit CAGR of 18.4% to reach $470.9 million by 2019 from $202.5 million in 2014. Developing markets such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations.

TOPICS:
Advertisement

Surgeon General: 'Desperate Need of Clarity' on e-Cigarettes

January 27, 2015 3:29 pm | by MICHAEL FELBERBAUM, AP Tobacco Writer | News | Comments

The U.S. surgeon general says officials are "in desperate need of clarity" on electronic cigarettes to help guide public health policies.                   

TOPICS:

Donors Pledge $7.5B for Global Vaccines Program

January 27, 2015 2:10 pm | News | Comments

Governments and private donors, among them the Bill and Melinda Gates Foundation, have pledged a record $7.5 billion to replenish a global vaccination program for the poor.             

TOPICS:

Procter & Gamble's Fiscal Second Quarter Earnings Drop 31%

January 27, 2015 12:56 pm | by TOM MURPHY, AP Business Writers; CANDICE CHOI, AP Business Writers | News | Comments

The Cincinnati company, which sells products ranging from Tide detergent to Crest toothpaste, said Tuesday that exchange rates will remain a challenge well into fiscal 2015, especially in the second half of its year. Overall, it expects foreign exchange to chop its core, fiscal 2015 earnings by 12 percent and reduce its revenue by 5 percent.

TOPICS:

Pfizer Net Down on Lower Sales, Higher Research, Legal Costs

January 27, 2015 12:53 pm | by LINDA A. JOHNSON, AP Business Writer | News | Comments

Pfizer's fourth-quarter profit fell by half as worsening generic competition and unfavorable currency rates reduced sales, and higher research spending and legal costs also hurt the bottom line. The world's second-biggest drugmaker by revenue reported lower sales for most of its huge portfolio of prescription medicines, with the biggest hit coming from new generic competition to popular painkiller Celebrex.

TOPICS:

12th Annual Biopharmaceutical Manufacturing Report and Survey

January 27, 2015 11:47 am | News | Comments

Your input is important as BioPlan Associates, Inc., benchmarks global and regional trends affecting our industry.  You will receive a FREE summary of the results of this important global study; our 159 Key Industry Facts White Paper; AND for each completed survey BioPlan will donate $10 (up to $10,000) to global health charities.

TOPICS:
Advertisement

Pfizer Beats Wall Street Fourth Quarter Forecasts

January 27, 2015 7:42 am | News | Comments

Pfizer on Tuesday reported fourth-quarter earnings of $1.23B. On a per-share basis, the company said it had net income of 19 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, came to 54 cents per share.

TOPICS:

FDA Names Deputy Commissioner for Medical Products and Tobacco

January 27, 2015 7:28 am | News | Comments

U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D., has appointed Robert Califf, M.D., a recognized global leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Medical Products and Tobacco. 

TOPICS:

VA to Create Unified Framework with Five Service Regions

January 27, 2015 7:14 am | by MATTHEW DALY, Associated Press | News | Comments

The new framework is part of a larger reorganization that VA leaders say will bring a singular focus on customer service to an agency that serves 22 million veterans, including more than 6 million who receive health care each year from the VA's 970 hospitals or clinics.

TOPICS:

FDA Approves Teva's Generic Nexium® Delayed-Release Capsules

January 27, 2015 7:06 am | News | Comments

Teva Pharmaceutical has announced the Food and Drug Administration (FDA) approval of the first generic equivalent to Nexium (esomeprazole magnesium) Delayed-Release Capsules in the United States.         

TOPICS:

Inherited Gene Variation Helps Explain Drug Toxicity in Patients Of East Asian Ancestry

January 27, 2015 7:01 am | News | Comments

About 10 percent of young leukemia patients of East Asian ancestry inherit a gene variation that is associated with reduced tolerance of a drug that is indispensable for curing acute lymphoblastic leukemia (ALL), the most common childhood cancer.

TOPICS:

Novartis Posts Fourth Quarter Profit Drop

January 27, 2015 6:53 am | News | Comments

Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit. The Basel, Switzerland-based company said Tuesday that fourth quarter net income came in at $1.49 billion, down from $2 billion in the same quarter the year before.

TOPICS:

Government to Overhaul Medicare Payments to Doctors, Hospitals

January 26, 2015 12:51 pm | by RICARDO ALONSO-ZALDIVAR, Associated Press | News | Comments

The Obama administration has announced a plan to shift Medicare payments it makes to hospitals and doctors so they reward quality over volume. Officials said they hoped the move would be a catalyst for the entire health-care system.   

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading